Advertisement
Advertisement
CRVS
Corvus Pharmaceuticals, Inc.
11.62
USDSponsored
-0.18
-1.53%
Sep 25, 15:59 UTC -4
Closed
After-Market
11.64
+0.02
+0.17%
Corvus Pharmaceuticals, Inc. Financial Snapshot
| Market Cap | 979.17M |
| Beta | 0.87 |
| Earnings Per Share (EPS) | -0.61 |
| Price-to-Book (P/B) Ratio | 4.40 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -36.15% |
| Current Ratio | 16.16% |
| Free Cash Flow | -26.45M |
